Boehringer Ingelheim, a pharmaceuticals maker has agreed to pay (Dollar) 650 million to settle the 4,000 lawsuits related to its blood-thinning drug Pradaxa. "Boehringer Ingelheim announced today that the company has reached a comprehensive settlement of state and federal cases in the US litigation regarding Pradaxa," it said in a statement. Boehringer Ingelheim insisted that it continued to stand behind the drug, which is used to prevent blood clots and stroke ...Friday 30 May 2014
Boehringer Ingelheim Ready to Pay (Dollar) 650 Mn to Settle Pradaxa Lawsuits
Boehringer Ingelheim, a pharmaceuticals maker has agreed to pay (Dollar) 650 million to settle the 4,000 lawsuits related to its blood-thinning drug Pradaxa. "Boehringer Ingelheim announced today that the company has reached a comprehensive settlement of state and federal cases in the US litigation regarding Pradaxa," it said in a statement. Boehringer Ingelheim insisted that it continued to stand behind the drug, which is used to prevent blood clots and stroke ...
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment